Treatment agent for synthetic fibers, method for filling container, and method for producing synthetic fibers

A synthetic fiber treatment agent with a smoothing agent, nonionic surfactant, and phosphorus compound, formulated to maintain stability and reduce tar cleaning issues, addresses performance deterioration in conventional agents.

JP7587896B1Active Publication Date: 2024-11-21TAKEMOTO OIL & FAT CO LTD

Patent Information

Application Number
JP2024056223
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Filing Date
2024-03-29
Publication Date
2024-11-21
Estimated Expiration
2044-03-29

AI Technical Summary

Technical Problem

Conventional synthetic fiber processing agents deteriorate in performance over time, especially when stored at high temperatures for extended periods.

Method used

A synthetic fiber treatment agent comprising a specified smoothing agent, nonionic surfactant, and phosphorus compound, with a pH of 6.0 to 9.0, and a formulation with controlled component ratios to maintain stability.

Benefits of technology

The agent maintains performance stability even after long-term storage, particularly at high temperatures, reducing tar cleaning issues on spinning equipment.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007587896000001
    Figure 0007587896000001
  • Figure 0007587896000002
    Figure 0007587896000002
  • Figure 0007587896000003
    Figure 0007587896000003
Patent Text Reader

Abstract

The present invention provides a synthetic fiber processing agent capable of suppressing deterioration in the performance of the synthetic fiber processing agent even when stored for a long period of time, a method for filling a container using the same, and synthetic fibers. [Solution] The synthetic fiber treatment agent of the present invention contains a smoothing agent (A) which is a complete ester compound of an alcohol and a fatty acid, a nonionic surfactant (B), and the following phosphorus compound (C), and is characterized in that the pH of a 1% by mass aqueous solution of the synthetic fiber treatment agent is 6.0 to 9.0. The phosphorus compound (C) is at least one selected from a specified phosphate ester (C1), an organic phosphite ester (C2), and an organic phosphonate ester (C3).
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to a synthetic fiber treatment agent, a method for filling the same into a container, and a synthetic fiber treatment agent having the synthetic fiber treatment agent attached thereto. Manufacturing method Regarding. [Background technology]

[0002] For example, in the spinning and drawing process and finishing process of synthetic fibers, a treatment for attaching a synthetic fiber treating agent to the surface of the fiber may be carried out from the viewpoint of reducing friction of the fiber, preventing static electricity, and improving bundling ability.

[0003] For example, conventionally known synthetic fiber treating agents are disclosed in Patent Documents 1 to 6. Patent Document 1 discloses a synthetic fiber treating agent comprising a smoothing agent and a specified phosphoric acid compound blended therein. Patent Document 2 discloses a synthetic fiber treating agent that contains a smoothing component, a specific organic sulfonic acid compound, and an organic phosphate ester compound.

[0004] Patent Document 3 discloses a synthetic fiber spinning oil for false twist processing, which contains a polyether lubricant, a fluorine-containing crosslinked polymer, and optionally one or more components selected from a surfactant, an antistatic agent, and a pH adjuster.

[0005] Patent Document 4 discloses a synthetic fiber filament yarn method in which an aqueous solution of a predetermined lubricant, the pH of which is adjusted to 7 to 9, is applied to a synthetic fiber filament yarn so that the lubricant is 0.1 to 3 wt % and the water content is 0.2 to 10 times the amount of lubricant applied, and the synthetic fiber filament yarn to which the aqueous solution has been applied is then subjected to a contact heater type false twist texturing.

[0006] Patent Document 5 discloses a synthetic fiber treating agent containing a polyoxyalkylene alkyl ether component having a specified weight average molecular weight and a polyoxyalkylene polyether component having a specified weight average molecular weight.

[0007] Patent Document 6 describes a synthetic fiber treatment agent containing a specific polyoxyalkylene alkyl ether, in which the kinetic viscosity of an aqueous solution of the treatment agent having a non-volatile content of 10% by weight at 25°C is 2.0 to 3.0 mm 2 The present invention discloses a synthetic fiber treatment agent comprising: [Prior art documents] [Patent documents]

[0008] [Patent Document 1] Patent No. 5500745 [Patent Document 2] Patent No. 5793607 [Patent Document 3] Patent No. 3762336 [Patent Document 4] Patent No. 3649422 [Patent Document 5] International Publication No. 2019 / 138866 [Patent Document 6] Patent No. 6625449 Summary of the Invention [Problem to be solved by the invention]

[0009] However, conventional synthetic fiber treatment agents have a problem in that their performance deteriorates after long-term storage, particularly when the agent is stored at high temperatures for a long period of time. [Means for solving the problem]

[0010] As a result of research aimed at solving the above-mentioned problems, the present inventors have found that, in a treatment agent for synthetic fibers containing a specified smoothing agent (A), a nonionic surfactant (B), and a phosphorus compound (C), a composition in which the pH of a 1% by mass aqueous solution of the treatment agent for synthetic fibers is 6.0 or more and 9.0 or less is precisely suitable.

[0011] Various aspects for solving the above problems will be described below. The treatment agent for synthetic fibers in aspect 1 contains the following smoothing agent (A), nonionic surfactant (B), and phosphorus compound (C), and is characterized in that a 1% by mass aqueous solution of the treatment agent for synthetic fibers has a pH of 6.0 or more and 9.0 or less.

[0012] Smoothing agent (A): A complete ester compound of alcohol and fatty acid. Phosphorus compound (C): at least one selected from the following phosphate ester (C1), organic phosphite ester (C2), and organic phosphonate ester (C3).

[0013] Phosphate ester (C1): A phosphate ester including a phosphate ester (C1a) represented by the following formula (1), a phosphate ester (C1b) represented by the following formula (2), and a phosphate ester (C1c) represented by the following formula (3).

[0014] [ka] (In formula (1), R 1 : A residue obtained by removing a hydroxyl group from an aliphatic monohydric alcohol having 8 to 24 carbon atoms, or a residue obtained by removing a hydroxyl group from an alkylene oxide having 2 to 3 carbon atoms (inclusive) added in total to 1 mole or more and 20 moles or less per mole of an aliphatic monohydric alcohol having 8 to 24 carbon atoms.

[0015] M 1 ,M 2 : Hydrogen atom, alkali metal, alkaline earth metal (1 / 2), organic amine salt, ammonium, or phosphonium.

[0016] [ka] (In formula (2), R 2 ,R 3: A residue obtained by removing a hydroxyl group from an aliphatic monohydric alcohol having 8 to 24 carbon atoms, or a residue obtained by removing a hydroxyl group from an alkylene oxide having 2 to 3 carbon atoms (inclusive) added in total to 1 mole or more and 20 moles or less per mole of an aliphatic monohydric alcohol having 8 to 24 carbon atoms.

[0017] M 3 : Hydrogen atom, alkali metal, alkaline earth metal (1 / 2), organic amine salt, ammonium, or phosphonium.

[0018] [ka] (In formula (3), R 4 ,R 5 : A residue obtained by removing a hydroxyl group from an aliphatic monohydric alcohol having 8 to 24 carbon atoms, or a residue obtained by removing a hydroxyl group from an alkylene oxide having 2 to 3 carbon atoms (inclusive) added in total to 1 mole or more and 20 moles or less per mole of an aliphatic monohydric alcohol having 8 to 24 carbon atoms.

[0019] n: an integer of 2 or 3. M 4 : Hydrogen atom, alkali metal, alkaline earth metal (1 / 2), organic amine salt, ammonium, or phosphonium. However, M 4 If there are two or more, they may be the same or different.) In a second aspect, in the agent for treating synthetic fibers according to the first aspect, the phosphorus compound (C) is a phosphoric acid ester (C1).

[0020] In a third aspect, in the treatment agent for synthetic fibers according to the first or second aspect, the smoothing agent (A) comprises a complete ester compound (A1) of a polyhydric alcohol and a monohydric fatty acid, and the molecular weight of the complete ester compound (A1) of a polyhydric alcohol and a monohydric fatty acid is 700 or more.

[0021] Aspect 4 is the synthetic fiber treating agent according to any one of Aspects 1 to 3, wherein, when the total content of the smoothing agent (A), the nonionic surfactant (B), and the phosphorus compound (C) is taken as 100 mass%, the smoothing agent (A) is contained in an amount of from 20 mass% to 70 mass%; the nonionic surfactant (B) is contained in an amount of from 20 mass% to 79.999 mass%; and the phosphorus compound (C) is contained in an amount of from 0.001 mass% to 10 mass%.

[0022] A fifth aspect is the agent for treating synthetic fibers according to any one of the first to fourth aspects, further comprising water, wherein the content of water in the agent for treating synthetic fibers is from 0.001% by mass to 10% by mass.

[0023] A sixth aspect is the treating agent for synthetic fibers according to any one of the first to fifth aspects, further comprising a nitrogen-containing antioxidant (D). In a seventh aspect, the synthetic fiber treating agent according to any one of the first to sixth aspects further contains the following high molecular weight compound (E).

[0024] High molecular weight compound (E): A compound that contains a carbonyl group in the molecule and has a mass average molecular weight of 4,000 or more. The method for filling a container according to the eighth embodiment is a method for filling the container with the treating agent for synthetic fibers according to any one of the first to seventh embodiments so that the filling rate relative to the volume of the container is 80% or more.

[0025] The synthetic fiber of embodiment 9 Manufacturing method The synthetic fiber treating agent according to any one of aspects 1 to 7. to a synthetic fiber. It is characterized by: Effect of the Invention

[0026] According to the present invention, deterioration in the performance of a treating agent for synthetic fibers can be suppressed even when the agent is stored for a long period of time. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0027] First Embodiment A first embodiment of the synthetic fiber treatment agent of the present invention (hereinafter, simply referred to as the treatment agent) will be described below. The treatment agent of this embodiment contains the following smoothing agent (A), nonionic surfactant (B), and phosphorus compound (C). The treatment agent may further contain a solvent, a nitrogen-containing antioxidant (D), and a specified high molecular weight compound (E).

[0028] (Smoothing agent (A)) The smoothing agent used in this embodiment may be a complete ester compound of an alcohol and a fatty acid. An example of the complete ester compound is an ester oil produced from an alcohol and a fatty acid having a hydrocarbon group, which will be described later.

[0029] The fatty acid as the raw material of the complete ester compound is not particularly limited with respect to its carbon number, the presence or absence of branching, valence, etc., and may be, for example, a higher fatty acid, a fatty acid having a cyclo ring, or a fatty acid having an aromatic ring. The alcohol as the raw material of the complete ester compound is not particularly limited with respect to its carbon number, the presence or absence of branching, valence, etc., and may be, for example, a higher alcohol, an alcohol having a cyclo ring, or an alcohol having an aromatic ring.

[0030] Specific examples of complete ester compounds include, for example, (1) ester compounds of aliphatic monoalcohols and aliphatic monocarboxylic acids, such as 2-ethylhexyl stearate, octyl palmitate, oleyl laurate, oleyl oleate, isotridecyl stearate, and isotetracosyl oleate; (2) complete ester compounds of aliphatic polyhydric alcohols and aliphatic monocarboxylic acids, such as 1,6-hexanediol didecanate, glycerin trioleate, trimethylolpropane trilaurate, pentaerythritol tetraoctate, and trimethylolpropane tripal fatty acid ester; (3) dioleyl azelate, dioleyl thiodipropionate, and diisostearate. (4) ester compounds of aromatic monoalcohols and aliphatic monocarboxylic acids, such as benzyl oleate and benzyl laurate; (5) complete ester compounds of aromatic polyhydric alcohols and aliphatic monocarboxylic acids, such as bisphenol A dilaurate; (6) complete ester compounds of aliphatic monoalcohols and aromatic polycarboxylic acids, such as bis-2-ethylhexyl phthalate, diisostearyl isophthalate and trioctyl trimellitate; and (7) natural oils and fats, such as palm oil, coconut oil, rapeseed oil, sunflower oil, soybean oil, castor oil, sesame oil, fish oil, and beef tallow.

[0031] These smoothing agents (A) may be used alone or in appropriate combination of two or more. Among these, it is preferable that the smoothing agent (A) contains a complete ester compound (A1) of a polyhydric alcohol and a monovalent fatty acid. More specifically, it is preferable that the smoothing agent (A) contains the above compounds (2) and (7). Furthermore, it is preferable that the molecular weight of the complete ester compound (A1) of a polyhydric alcohol and a monovalent fatty acid ester is 700 or more. By containing such a compound, the deterioration of the performance of the treatment agent can be further suppressed even during long-term storage.

[0032] The lower limit of the content of the smoothing agent (A) in the treatment agent is appropriately set, but is preferably 20% by mass or more, more preferably 30% by mass or more. When the content is 20% by mass or more, the smoothness of the fiber to which the treatment agent is applied can be improved. In addition, even if the treatment agent is stored for a long period of time, the deterioration of the performance of the treatment agent can be further suppressed. The upper limit of the content of the smoothing agent (A) is appropriately set, but is preferably 70% by mass or less, more preferably 65% ​​by mass or less. When the content is 70% by mass or less, the stability of the treatment agent can be improved. In addition, even if the treatment agent is stored for a long period of time, the deterioration of the performance of the treatment agent can be further suppressed. Note that a range in which the above upper and lower limits are arbitrarily combined is also envisaged.

[0033] (Nonionic surfactant (B)) Examples of the nonionic surfactant (B) include compounds having a (poly)oxyalkylene structure in which alkylene oxide is added to alcohols or carboxylic acids, ether / ester compounds having a (poly)oxyalkylene structure in which alkylene oxide is added to an ester compound of carboxylic acids and polyhydric alcohol, amine compounds having a (poly)oxyalkylene structure in which alkylene oxide is added to a primary organic amine, partial ester compounds of carboxylic acids and polyhydric alcohols, amide compounds in which amine compounds and carboxylic acids are condensed, compounds having a (poly)oxyalkylene structure in which alkylene oxide is added to fatty acid amides, compounds having a polyoxyalkylene structure such as block copolymers having polyoxyethylene chains and polyoxypropylene chains, etc. It should be noted that these do not include compounds that fall under the category of high molecular weight compounds (E) described below.

[0034] Specific examples of alcohols used as raw materials for the nonionic surfactant (B) include, for example, (1) linear alkyl alcohols such as methanol, ethanol, propanol, butanol, pentanol, hexanol, octanol, nonanol, decanol, undecanol, dodecanol, tridecanol, tetradecanol, pentadecanol, hexadecanol, heptadecanol, octadecanol, nonadecanol, eicosanol, heneicosanol, docosanol, tricosanol, tetracosanol, pentacosanol, hexacosanol, heptacosanol, octacosanol, nonacosanol, and triacontanol; (2) isopropanol, isobutanol, isohexanol, 2-ethylhexanol, isononanol, isodecanol, isododecanol, isotridecanol, isotetradecanol, isopentadecanol, and isohexanol. Branched alkyl alcohols such as sadecanol, isoheptadecanol, isooctadecanol, isonadecanol, isoeicosanol, isoheneicosanol, isodocosanol, isotricosanol, isotetracosanol, isopentacosanol, isohexacosanol, isoheptacosanol, isooctacosanol, isononacosanol, and isotriacontanol; (3) linear alkenyl alcohols such as tetradecenol, hexadecenol, heptadecenol, octadecenol, and nonadecenol; (4) branched alkenyl alcohols such as isohexadecenol and isooctadecenol; (5) cyclic alkyl alcohols such as cyclopentanol and cyclohexanol; and (6) aromatic alcohols such as phenol, nonylphenol, benzyl alcohol, monostyrenated phenol, distyrenated phenol, and tristyrenated phenol.

[0035] Specific examples of carboxylic acids used as raw materials for the nonionic surfactant (B) include: (1) linear alkyl carboxylic acids such as octylic acid, nonanoic acid, decanoic acid, undecanoic acid, dodecanoic acid, tridecanoic acid, tetradecanoic acid, pentadecanoic acid, hexadecanoic acid, heptadecanoic acid, octadecanoic acid, nonadecanoic acid, eicosanoic acid, heneicosanoic acid, and docosanoic acid; (2) branched alkyl carboxylic acids such as 2-ethylhexanoic acid, isododecanoic acid, isotridecanoic acid, isotetradecanoic acid, isohexadecanoic acid, and isooctadecanoic acid; (3) linear alkenyl carboxylic acids such as octadecenoic acid, octadecadienoic acid, and octadecatrienoic acid; (4) aromatic carboxylic acids such as benzoic acid; (5) hydroxycarboxylic acids such as lactic acid, citric acid, and ricinoleic acid; and (6) polyvalent carboxylic acids such as adipic acid, sebacic acid, and tricarbaryl.

[0036] The alkylene oxide used as a raw material for forming the (poly)oxyalkylene structure of the nonionic surfactant (B) is preferably an alkylene oxide having 2 to 4 carbon atoms. Specific examples of the alkylene oxide include, for example, ethylene oxide, propylene oxide, and butylene oxide. The number of moles of the alkylene oxide added is appropriately set, but is preferably 0.1 moles or more and 60 moles or less, more preferably 1 moles or more and 40 moles or less, and even more preferably 2 moles or more and 30 moles or less. A range in which the above upper and lower limits are arbitrarily combined is also assumed. The number of moles of the alkylene oxide added indicates the number of moles of the alkylene oxide relative to 1 mole of the compound to be added in the charged raw material. The alkylene oxide may be one type of alkylene oxide used alone, or two or more types of alkylene oxides may be used in appropriate combination. When two or more types of alkylene oxides are used, the addition form may be any of block addition, random addition, and a combination of block addition and random addition, and is not particularly limited.

[0037] Specific examples of polyhydric alcohols used as a raw material for the nonionic surfactant (B) include ethylene glycol, propylene glycol, 1,3-propanediol, 1,2-butanediol, 1,3-butanediol, 1,4-butanediol, 2-methyl-1,2-propanediol, 1,5-pentanediol, 1,6-hexanediol, 2,5-hexanediol, 2-methyl-2,4-pentanediol, 2,3-dimethyl-2,3-butanediol, glycerin, 2-methyl-2-hydroxymethyl-1,3-propanediol, trimethylolpropane, sorbitan, pentaerythritol, and sorbitol.

[0038] Specific examples of the aliphatic amine used as a raw material for the nonionic surfactant (B) include methylamine, ethylamine, butylamine, octylamine, laurylamine, octadecylamine, octadecenylamine, and coconut amine.

[0039] Specific examples of fatty acid amides used as raw materials for the nonionic surfactant (B) include, for example, octylic acid amide, lauric acid amide, palmitic acid amide, stearic acid amide, oleic acid amide, behenic acid amide, lignoceric acid amide, amides of fatty acids and diethanolamine, and amides of fatty acids and ethyleneamine.

[0040] Specific examples of the nonionic surfactant (B) include a compound in which an alkylene oxide is added to hydrogenated castor oil, a diester of polyethylene glycol and oleic acid, a compound in which ethylene oxide and propylene oxide are randomly added to cetyl alcohol, a compound in which an alkylene oxide is added to a mixed alcohol having 12 and 13 carbon atoms, a compound in which an alkylene oxide is added to laurylamine, and a compound in which an alkylene oxide is added to stearylamine.

[0041] These nonionic surfactants (B) may be used alone or in appropriate combination of two or more kinds. The lower limit of the content of the nonionic surfactant (B) in the treatment agent is appropriately set, but is preferably 20% by mass or more, more preferably 25% by mass or more. When the content is 20% by mass or more, the stability of the treatment agent can be improved. In addition, even if the treatment agent is stored for a long period of time, the deterioration of the performance of the treatment agent can be further suppressed. The upper limit of the content of the nonionic surfactant (B) is appropriately set, but is preferably 79.999% by mass or less, more preferably 70% by mass or less. When the content is 79.999% by mass or less, the stability of the treatment agent can be improved. In addition, even if the treatment agent is stored for a long period of time, the deterioration of the performance of the treatment agent can be further suppressed. In addition, a range in which the above upper and lower limits are arbitrarily combined is also envisaged.

[0042] (Phosphorus Compounds (C)) The phosphorus compound (C) is at least one selected from the following phosphoric acid ester (C1), organic phosphorous acid ester (C2), and organic phosphonic acid ester (C3). Among these, the phosphorus compound (C) is preferably the phosphoric acid ester (C1). By using the phosphoric acid ester (C1), the deterioration of the performance of the treatment agent can be further suppressed even when the treatment agent is stored for a long period of time.

[0043] The phosphate ester (C1) is a phosphate ester containing a phosphate ester (C1a) represented by the following formula (1), a phosphate ester (C1b) represented by the following formula (2), and a phosphate ester (C1c) represented by the following formula (3).

[0044] [ka] (In formula (1), R 1 : A residue obtained by removing a hydroxyl group from an aliphatic monohydric alcohol having 8 to 24 carbon atoms, or a residue obtained by removing a hydroxyl group from an alkylene oxide having 2 to 3 carbon atoms (inclusive) added in total to 1 mole or more and 20 moles or less per mole of an aliphatic monohydric alcohol having 8 to 24 carbon atoms.

[0045] M 1 ,M2 : Hydrogen atom, alkali metal, alkaline earth metal (1 / 2), organic amine salt, ammonium, or phosphonium. The aliphatic monohydric alcohol may be a saturated aliphatic alcohol or an unsaturated aliphatic alcohol, and may have a straight chain structure or a branched chain structure.

[0046] Specific examples of aliphatic monohydric alcohols include, for example, (1) linear alkyl alcohols such as octanol, nonanol, decanol, undecanol, dodecanol, tridecanol, tetradecanol, pentadecanol, hexadecanol, heptadecanol, octadecanol, nonadecanol, eicosanol, heneicosanol, docosanol, tricosanol, and tetracosanol; and (2) 2-ethylhexanol, isononanol, isodecanol, isododecanol, isotridecanol, and isotetradecanol. (3) branched alkyl alcohols such as tetradecenol, hexadecanol, heptadecanol, octadecenol, oleyl alcohol, and nonadecenol; and (4) branched alkenyl alcohols such as isohexadecanol and isooctadecenol.

[0047] Specific examples of alkylene oxide include ethylene oxide and propylene oxide. The number of moles of alkylene oxide added per mole of aliphatic monohydric alcohol having 8 to 24 carbon atoms is 1 to 20 moles, preferably 2 to 15 moles. Any combination of the upper and lower limits is also possible. The number of moles of alkylene oxide added indicates the number of moles of alkylene oxide per mole of aliphatic alcohol compound in the raw material. The alkylene oxide may be one type of alkylene oxide used alone, or two types of alkylene oxides may be used in appropriate combination. When two types of alkylene oxide are used, the addition form may be any of block addition, random addition, and a combination of block addition and random addition, and is not particularly limited.

[0048] M 1 Or M 2 represents a hydrogen atom, an alkali metal, an alkaline earth metal (1 / 2), an organic amine salt, ammonium, or phosphonium. Note that alkaline earth metals are divalent, so alkaline earth metals (1 / 2) are represented by M 1 Or M 2 In the above formula, 1 / 2 mole of the metal is added. Specific examples of the alkali metal include sodium, potassium, and lithium. Specific examples of the alkaline earth metal include magnesium and calcium.

[0049] Specific examples of organic amines include: (1) aliphatic amines such as methylamine, dimethylamine, trimethylamine, ethylamine, diethylamine, triethylamine, N-diisopropylethylamine, butylamine, dibutylamine, 2-methylbutylamine, tributylamine, octylamine, laurylamine, and dimethyllaurylamine; (2) aromatic amines or heterocyclic amines such as aniline, N-methylbenzylamine, pyridine, morpholine, piperazine, and derivatives thereof; (3) alkanolamines such as monoethanolamine, N-methylethanolamine, diethanolamine, triethanolamine, isopropanolamine, diisopropanolamine, triisopropanolamine, dibutylethanolamine, butyldiethanolamine, octyldiethanolamine, and lauryldiethanolamine; (4) arylamines such as 3-aminopropene; and (5) polyoxyalkylene alkylamino ethers such as polyoxyethylene lauryl amino ether and polyoxyethylene steryl amino ether.

[0050] Specific examples of the phosphonium include quaternary phosphoniums such as tetramethylphosphonium, tetraethylphosphonium, tetrabutylphosphonium, tetraoctylphosphonium, dibutyldihexylphosphonium, trihexyltetradecylphosphonium, triethyloctylphosphonium, and triphenylmethylphosphonium.

[0051] [ka] (In formula (2), R 2 ,R 3 : A residue obtained by removing a hydroxyl group from an aliphatic monohydric alcohol having 8 to 24 carbon atoms, or a residue obtained by removing a hydroxyl group from an alkylene oxide having 2 to 3 carbon atoms (inclusive) added in total to 1 mole or more and 20 moles or less per mole of an aliphatic monohydric alcohol having 8 to 24 carbon atoms.

[0052] M 3: Hydrogen atom, alkali metal, alkaline earth metal (1 / 2), organic amine salt, ammonium, or phosphonium. R 2 or R 3 Specific examples of the residue obtained by removing a hydroxyl group from an aliphatic monohydric alcohol having 8 to 24 carbon atoms, or the residue obtained by removing a hydroxyl group from an alkylene oxide having 2 to 3 carbon atoms added in a total amount of 1 mole to 20 moles per mole of an aliphatic monohydric alcohol having 8 to 24 carbon atoms, include R 1 The specific examples listed in the above can be adopted.

[0053] M 3 Specific examples of the formula (1) include M 1 Or M 2 Examples of the examples are given in the above.

[0054] [ka] (In formula (3), R 4 ,R 5 : A residue obtained by removing a hydroxyl group from an aliphatic monohydric alcohol having 8 to 24 carbon atoms, or a residue obtained by removing a hydroxyl group from an alkylene oxide having 2 to 3 carbon atoms (inclusive) added in total to 1 mole or more and 20 moles or less per mole of an aliphatic monohydric alcohol having 8 to 24 carbon atoms.

[0055] n: an integer of 2 or 3. M 4 : Hydrogen atom, alkali metal, alkaline earth metal (1 / 2), organic amine salt, ammonium, or phosphonium. However, M 4 If there are two or more, they may be the same or different.) R 4 or R 5 Specific examples of the residue obtained by removing a hydroxyl group from an aliphatic monohydric alcohol having 8 to 24 carbon atoms, or the residue obtained by removing a hydroxyl group from an alkylene oxide having 2 to 3 carbon atoms added in a total amount of 1 mole to 20 moles per mole of an aliphatic monohydric alcohol having 8 to 24 carbon atoms, include R1 The specific examples listed in the above can be adopted.

[0056] M 4 Specific examples of the formula (1) include M 1 Or M 2 Examples of the examples are given in the above. In the P nuclear NMR measurement of the alkali overneutralized pretreated phosphate ester (C1), the P nuclear NMR integral ratios attributable to the phosphate ester (C1a), the phosphate ester (C1b), the phosphate ester (C1c), and inorganic phosphoric acid or a salt thereof are not particularly limited. When the total of the P nuclear NMR integral ratios attributable to the phosphate ester (C1a), the phosphate ester (C1b), the phosphate ester (C1c), and inorganic phosphoric acid or a salt thereof is taken as 100%, the P nuclear NMR integral ratio attributable to the phosphate ester (C1c) is preferably 1% or more and 90% or less, more preferably 10% or more and 80% or less, and even more preferably 15% or more and 70% or less.

[0057] When the P nuclear NMR integral ratio assigned to the phosphate ester (C1c) is in the above-mentioned numerical range, deterioration of the performance of the treatment agent can be further suppressed even when the treatment agent is stored for a long period of time. The above-mentioned "alkaline overneutralization pretreatment" means a pretreatment in which an excess amount of alkali is added to the phosphate ester compound. Specific examples of the alkali are not particularly limited, and include, for example, organic amines, hydroxides of alkali metals or alkaline earth metals, etc. Furthermore, the alkali may be the same as or different from the alkali used in synthesizing the phosphate ester salt. Specific examples of the organic amine include those exemplified as the organic amines constituting the above-mentioned phosphate ester salt. Specific examples of the hydroxides of alkali metals or alkaline earth metals include, for example, sodium hydroxide, potassium hydroxide, magnesium hydroxide, etc.

[0058] Specific examples of the phosphate ester (C1) include a salt of a compound in which isocetyl alcohol is phosphorylated and a compound in which 10 moles of ethylene oxide are added to 1 mole of laurylamine, and a compound in which isocetyl alcohol is phosphorylated.

[0059] Organic phosphite (C2) is a phosphoric acid compound (P(OR)3) with an organic group (R: substituent) on phosphorous acid (P(OH)3). Organic phosphonate (C3) is a phosphoric acid compound (RP(O)(OR)2) with a substituent (R) on phosphonic acid (HP(O)(OH)2). P(OR)3 (phosphite) tautomerizes to RP(=O)(OR)2 (phosphonate).

[0060] Substituents constituting the organic phosphite ester (C2) or the organic phosphonate ester (C3) include an aliphatic hydrocarbon group, an aromatic hydrocarbon group, etc. When a plurality of substituents are present in one molecule, the substituents may be the same or different. In addition, they may be monoesters, diesters, or triesters.

[0061] The hydrocarbon group may be a saturated or unsaturated hydrocarbon group, and may be a straight-chain or branched-chain hydrocarbon group.

[0062] The unsaturated hydrocarbon group may be an alkenyl group having one double bond as an unsaturated carbon bond, an alkadienyl group having two or more double bonds, an alkatrienyl group, etc., or an alkynyl group having one triple bond as an unsaturated carbon bond, or an alkadiynyl group having two or more triple bonds, etc.

[0063] The number of carbon atoms constituting the hydrocarbon group is not particularly limited, and may be, for example, 1 or more and 30 or less. Specific examples of linear saturated hydrocarbon groups include, for example, methyl, ethyl, propyl, butyl, pentyl, hexyl, heptyl, octyl, nonyl, decyl, undecyl, dodecyl, tridecyl, tetradecyl, pentadecyl, hexadecyl, heptadecyl, octadecyl, icosyl, docosyl, and tricosyl groups.

[0064] Specific examples of branched saturated hydrocarbon groups include isobutyl, isopentyl, isohexyl, isoheptyl, isooctyl, isononyl, isodecyl, isoundecyl, isododecyl, isotridecyl, isotetradecyl, isopentadecyl, isohexadecyl, isoheptadecyl, isooctadecyl, isoicosyl, isodocosyl, and isotricosyl groups.

[0065] Specific examples of linear unsaturated hydrocarbon groups having one double bond in the hydrocarbon group include butenyl, pentenyl, hexenyl, heptenyl, octenyl, nonenyl, decenyl, undecenyl, dodecenyl, tridecenyl, tetradecenyl, pentadecenyl, hexadecenyl, heptadecenyl, octadecenyl, icosenyl, docosenyl, and tricosenyl groups.

[0066] The aromatic hydrocarbon group is not particularly limited as long as it is a hydrocarbon group having a single ring or a condensed ring as an aromatic ring, and examples thereof include aryl groups such as a phenyl group, a naphthyl group, a tolyl group, a xylyl group, and an alkylphenyl group.

[0067] Specific examples of the organic phosphite ester (C2) or the organic phosphonate ester (C3) include, for example, triphenyl phosphite, trisnonylphenyl phosphite, tricresyl phosphite, triethyl phosphite, tris(2-ethylhexyl) phosphite, tridecyl phosphite, tris(tridecyl) phosphite, trilauryl phosphite, tris(decyl / lauryl=1 / 1) phosphite, trioleyl phosphite, diphenyl mono(2-ethylhexyl) phosphite, diphenyl monodecyl phosphite, diphenyl mono(tridecyl) phosphite, tetraphenyl dipropyl phosphite, and the like. Examples of suitable phosphate esters include phenyl glycol diphosphite, tetraphenyl tetra(tridecyl)pentaerythritol tetraphosphite, tetra(alkyl having 12 to 15 carbon atoms)-4,4'-isopropylidenediphenyl diphosphite, bis(tridecyl)pentaerythritol diphosphite, bis(nonylphenyl)pentaerythritol diphosphite, 4,4'-butylidene-bis(3-methyl-6-t-butylphenyl-di-tridecyl phosphite), tristearyl phosphite, distearyl pentaerythritol diphosphite, and tris(2,4-di-t-butylphenyl)phosphite.

[0068] These phosphorus compounds (C) may be used alone or in appropriate combination of two or more. The lower limit of the content of the phosphorus compound (C) in the treatment agent is appropriately set, but is preferably 0.001% by mass or more, more preferably 0.01% by mass or more, and even more preferably 0.1% by mass or more. When the content is 0.001% by mass or more, the deterioration of the performance of the treatment agent can be further suppressed even when the treatment agent is stored for a long period of time. The upper limit of the content of the phosphorus compound (C) is appropriately set, but is preferably 10% by mass or less, more preferably 5% by mass or less. When the content is 10% by mass or less, the deterioration of the performance of the treatment agent can be further suppressed even when the treatment agent is stored for a long period of time. In addition, a range in which the above upper and lower limits are arbitrarily combined is also envisaged.

[0069] In the treatment agent, when the total content of the smoothing agent (A), the nonionic surfactant (B), and the phosphorus compound (C) is taken as 100% by mass, it is preferable that the smoothing agent (A) is contained in an amount of 20% by mass to 70% by mass, the nonionic surfactant (B) is contained in an amount of 20% by mass to 79.999% by mass, and the phosphorus compound (C) is contained in an amount of 0.001% by mass to 10% by mass. By specifying the content ratios within these ranges, deterioration of the performance of the treatment agent can be further suppressed even when the treatment agent is stored for a long period of time.

[0070] (pH) The lower limit of the pH (25°C) of a 1% by mass aqueous solution of the treatment agent is 6.0 or more, preferably 6.2 or more. When the pH is 6.0 or more, even if the treatment agent is stored for a long period of time, the deterioration of the performance of the treatment agent can be suppressed. The upper limit of the pH (25°C) of a 1% by mass aqueous solution of the treatment agent is 9.0 or less, preferably 8.7 or less. When the pH is 9.0 or less, even if the treatment agent is stored for a long period of time, the deterioration of the performance of the treatment agent can be suppressed. The pH of the ion-exchanged water used to dilute the treatment agent when measuring the pH is 6.0 to 7.0 (25°C), and the value is measured within 30 minutes after preparing a 1% by mass aqueous solution. When a solvent is contained in the treatment agent, the 1% by mass aqueous solution is a mixture containing the solvent.

[0071] (solvent) The treatment agent of this embodiment may contain a solvent if necessary. Examples of the solvent include water and organic solvents. Specific examples of the organic solvent include lower alcohols such as ethanol and propanol, and low-polarity solvents such as hexane and normal paraffin. These solvents may be used alone or in appropriate combination of two or more. Among these, water and normal paraffin having a carbon number of 10 to 15 are preferred from the viewpoints of excellent dispersibility or solubility of each component and excellent handling.

[0072] The lower limit of the water content in the treatment agent is appropriately set, but is preferably 0.001% by mass or more, more preferably 0.01% by mass or more, and even more preferably 0.1% by mass or more. When the content is 0.001% by mass or more, even if the treatment agent is stored for a long period of time, the deterioration of the performance of the treatment agent can be further suppressed. The upper limit of the water content is appropriately set, but is preferably 25% by mass or less, more preferably 15% by mass or less, and even more preferably 10% by mass or less. When the content is 25% by mass or less, even if the treatment agent is stored for a long period of time, the deterioration of the performance of the treatment agent can be further suppressed. In particular, even if the treatment agent is stored for a long period of time at high temperatures, the deterioration of the performance of the treatment agent can be suppressed. Note that ranges in which the above upper and lower limits are arbitrarily combined are also envisioned.

[0073] (Nitrogen-containing antioxidants (D)) The treatment agent of this embodiment may contain a nitrogen-containing antioxidant (D) as necessary. By containing the nitrogen-containing antioxidant (D) in the treatment agent, the deterioration of the performance of the treatment agent can be further suppressed even when the treatment agent is stored for a long period of time.

[0074] Specific examples of the nitrogen-containing antioxidant (D) include (1) phenolic antioxidants such as 1,3,5-tris(3',5'-di-t-butyl-4'-hydroxybenzyl)-s-triazine-2,4,6-(1H,3H,5H)trione and 1,3,5-tris(4-t-butyl-3-hydroxy-2,6-dimethylbenzyl)isocyanuric acid, (2) monoalkyldiphenylamine compounds such as monooctyldiphenylamine and monononyldiphenylamine; 4,4'-dibutyldiphenylamine, 4,4'-dipentyldiphenylamine, and 4,4'-dihexyldiphenylamine. dialkyldiphenylamine compounds such as 4,4'-diheptyldiphenylamine, 4,4'-dioctyldiphenylamine, 4,4'-dinonyldiphenylamine, and N-dinonyldiphenylamine; amine-based antioxidants such as polyalkyldiphenylamine compounds such as tetrabutyldiphenylamine, tetrahexyldiphenylamine, tetraoctyldiphenylamine, and tetranonyldiphenylamine; and (3) sulfur-based antioxidants such as 6-(4-hydroxy-3,5-di-tert-butylanilino)-2,4-bis(octylthio)-1,3,5-triazine.

[0075] These nitrogen-containing antioxidants (D) may be used alone or in appropriate combination of two or more. The lower limit of the content of the nitrogen-containing antioxidant (D) in the treatment agent is appropriately set, but is preferably 0.01% by mass or more, more preferably 0.1% by mass or more. When the content is 0.01% by mass or more, the deterioration of the performance of the treatment agent can be further suppressed even when the treatment agent is stored for a long period of time. The upper limit of the content of the nitrogen-containing antioxidant (D) is appropriately set, but is preferably 5% by mass or less, more preferably 3% by mass or less. When the content is 5% by mass or less, the deterioration of the performance of the treatment agent can be further suppressed even when the treatment agent is stored for a long period of time. It should be noted that a range in which the above upper and lower limits are arbitrarily combined is also envisaged.

[0076] (High molecular weight compound (E)) The treatment agent of this embodiment may contain a high molecular weight compound (E) as necessary. By containing the high molecular weight compound (E) in the treatment agent, the deterioration of the performance of the treatment agent can be further suppressed even when the treatment agent is stored for a long period of time. The high molecular weight compound (E) is a compound that contains a carbonyl group in the molecule and has a mass average molecular weight of 4000 or more. Examples of the carbonyl group include aldehydes, ketones, carboxylic acids, ester compounds, amide compounds, and imide compounds.

[0077] Specific examples of the high molecular weight compound (E) include compounds obtained by esterifying an ether / ester compound having a (poly)oxyalkylene structure, in which an alkylene oxide is added to an ester compound of a carboxylic acid and a polyhydric alcohol, with a carboxylic acid, a hydrogenated castor oil ethylene oxide adduct, a dibasic acid condensate of a hydrogenated castor oil ethylene oxide adduct, a compound in which the terminals of the above are blocked with a monovalent fatty acid, polybutenyl succinimide, polymethacrylate, etc.

[0078] These high molecular weight compounds (E) may be used alone or in appropriate combination of two or more. The lower limit of the content of the high molecular weight compound (E) in the treatment agent is appropriately set, but is preferably 0.1% by mass or more, more preferably 1% by mass or more. When the content is 0.1% by mass or more, the deterioration of the performance of the treatment agent can be further suppressed even when the treatment agent is stored for a long period of time. The upper limit of the content of the high molecular weight compound (E) is appropriately set, but is preferably 20% by mass or less, more preferably 10% by mass or less. When the content is 20% by mass or less, the deterioration of the performance of the treatment agent can be further suppressed even when the treatment agent is stored for a long period of time. In addition, a range in which the above upper and lower limits are arbitrarily combined is also envisioned.

[0079] (Effects of this embodiment) The effects of the treatment agent according to the first embodiment will be described. (1-1) The treatment agent of the first embodiment contains the smoothing agent (A), the nonionic surfactant (B), and the phosphorus compound (C), and the pH of a 1% by mass aqueous solution of the treatment agent is adjusted to 6.0 to 9.0. Therefore, even if the treatment agent is stored for a long period of time, the deterioration of the performance of the treatment agent can be suppressed. More specifically, the tar cleaning property on the drawing roller in the spinning process can be reduced.

[0080] In particular, even if the treatment agent is stored at high temperature for a long period of time, the deterioration of the performance of the treatment agent can be suppressed. More specifically, even if the treatment agent is stored at high temperature for a long period of time, the tar cleaning property on the drawing roller in the spinning process can be reduced.

[0081] <Second embodiment> The method of filling a container with a treatment agent according to the second embodiment is a method in which a step of preparing the treatment agent by mixing the above-mentioned components is first carried out, and then a step of filling the finished container with the mixed treatment agent at a predetermined filling rate relative to the volume of the container is carried out. The filling rate of the treatment agent in the finished container is preferably specified to be in the range of 80% by volume or more and 100% by volume or less as a filling rate calculated from the following formula (1) at 1 atmospheric pressure and 25°C.

[0082]

number

[0083] (Effects of this embodiment) The effect of the method of filling a container with a treatment agent according to the second embodiment will be described. (2-1) In the method of the second embodiment, the filling rate of the treatment agent in the container is set to 80% by volume or more. This reduces the amount of oxygen that the treatment agent comes into contact with, and suppresses the deterioration of the performance of the treatment agent. In particular, even if the treatment agent is stored at high temperatures for a long period of time, the deterioration of the performance of the treatment agent can be suppressed.

[0084] <Third embodiment> Next, a third embodiment of the synthetic fiber according to the present invention will be described. The synthetic fiber of this embodiment is a treated synthetic fiber having the non-volatile content of the treatment agent of the first embodiment attached to the surface. A modified synthetic fiber is obtained by attaching the treatment agent to the surface of the synthetic fiber. The non-volatile content refers to a treatment agent that has been heat-treated at 105°C for 2 hours to thoroughly remove volatile components. The treatment agent may be applied to the synthetic fiber in the form of a dilution solution diluted with a dilution solvent, such as an organic solvent solution or an aqueous liquid. As the dilution solvent, it is preferable to use a hydrocarbon having a carbon number of 10 to 15 and / or water from the viewpoint of the adhesion of the treatment agent to the fiber and economic efficiency. The synthetic fiber is obtained by a process of attaching a dilution solution such as an aqueous liquid to the synthetic fiber, for example, in a spinning or drawing process. The dilution solution attached to the synthetic fiber may be evaporated by a drawing process or a drying process. There is no particular restriction on the attachment process as long as it is a spinning process. The effects of the invention can be further enhanced by using the invention in manufacturing equipment or processes that include a step of passing the film through rollers at 150° C. or higher during the stretching or heat treatment process.

[0085] (Synthetic Fibers) Specific examples of synthetic fibers to which the treatment agent of this embodiment is applied are not particularly limited and include, for example, (1) polyester-based fibers such as polyethylene terephthalate (PET), polytrimethylene terephthalate, polybutylene terephthalate, polyethylene naphthalate, polylactic acid, and composite fibers containing these polyester-based resins, (2) polyamide-based fibers such as nylon 6 and nylon 66, (3) polyacrylic-based fibers such as polyacrylic and modacrylic, and (4) polyolefin-based fibers such as polyethylene and polypropylene. Of these, it is preferable to apply the treatment agent to polyester-based fibers and polyamide-based fibers.

[0086] There is no particular limit to the ratio of the treatment agent applied to the synthetic fibers, but it is preferable to apply the treatment agent at a ratio of 0.1% by mass to 3% by mass (excluding solvents such as water) relative to the synthetic fibers. This configuration further improves the effects of the present invention. There is also no particular limit to the method of applying the treatment agent, and known methods such as roller oiling, guide oiling using a metering pump, immersion oiling, and spray oiling can be used.

[0087] In the present invention, the use of the synthetic fiber is not particularly limited, but synthetic fibers used in industrial materials are preferred, such as fibers for airbags, seat belts, tire cords, carpets, tents, advertising fabrics, fishing nets, conveyor belts, ropes, and other synthetic fibers used in the fields of automobiles, architecture, commerce, agriculture, fisheries, civil engineering, and the like.

[0088] (Effects of this embodiment) The following describes the effects of the synthetic fiber of the third embodiment. In addition to the effects of the above embodiments, the third embodiment has the following effects.

[0089] (3-1) The synthetic fibers of the third embodiment are coated with the treatment agent of the first embodiment. Therefore, even if the treatment agent is stored for a long period of time, the various effects of each component, for example, the effect on long fibers, can be effectively exerted. In particular, the tar cleaning property can be improved.

[0090] (Example of change) The above embodiment may be modified as follows: The above embodiment and the following modifications may be combined with each other to the extent that no technical contradiction occurs.

[0091] Each of the treatment agents of the above embodiment may further contain other components used in normal treatment agents, such as other solvents, stabilizers, antistatic agents, binders, antioxidants other than those mentioned above, ultraviolet absorbers, organic acids, surfactants other than those mentioned above, smoothing agents other than those mentioned above, and pH adjusters, in order to maintain the quality of each treatment agent, within a range that does not impair the effects of the present invention. Examples of pH adjusters include phosphates and carboxylates having a pH buffering effect. The content of the pH adjuster in the non-volatile content of the treatment agent is preferably less than 2 mass% from the viewpoint of further improving the tar reduction effect. When a carboxylate is present in the treatment agent, the mass ratio of the carboxylate to the phosphorus compound (C) is preferably 2 / 1 to 1 / 100, more preferably 1 / 2 to 1 / 100, further preferably 1 / 10 to 1 / 100, and particularly preferably 1 / 20 to 1 / 100. In addition, the other components used in normal treatment agents, other than the solvent, are preferably 20 mass% or less in each treatment agent from the viewpoint of efficiently exerting the efficacy of the present invention. EXAMPLES

[0092] In the following, examples will be given to more specifically describe the configuration and effects of the present invention, but the present invention is not limited to these examples. In the following examples and comparative examples, parts means parts by mass, and % means % by mass.

[0093] Test category 1 (preparation of treatment agent) Example 1 The treatment agent of Example 1 contained 50 parts of trimethylolpropane tripartite fatty acid ester (molecular weight 890) (A-1a) as the smoothing agent (A), 20 parts of a compound (B-2b) obtained by esterifying 20 moles of ethylene oxide to 1 mole of hydrogenated castor oil with 2 moles of oleic acid as the nonionic surfactant (B), 19 parts of a diester of polyethylene glycol (mass average molecular weight 400) and oleic acid (B-3), 0.5 parts of a compound (B-6) obtained by adding 4 moles of ethylene oxide to 1 mole of laurylamine, and a compound (C) obtained by phosphorylating isocetyl alcohol and 10 moles of ethylene oxide to 1 mole of laurylamine. The treatment agent of Example 1 was prepared by adding 1 part of the salt with the added compound (C-1), 0.5 parts of 1,3,5-tris(4-t-butyl-3-hydroxy-2,6-dimethylbenzyl)isocyanuric acid (D-1) as the nitrogen-containing antioxidant (D), 4 parts of a compound (mass average molecular weight 6000) (E-1) obtained by adding 40 moles of ethylene oxide to 1 mole of hydrogenated castor oil and esterifying it with maleic acid and stearic acid as the high molecular weight compound, and 1 part of secondary alkyl (carbon number 12 to 18) sodium sulfonate (40% aqueous solution) (F-1) and 4 parts of normal paraffin (carbon numbers 12, 13, and 14) (F-5) as other components to a beaker and mixing them well.

[0094] (Examples 2 to 18, Comparative Examples 1 to 7) Each of the treatment agents of Examples 2 to 18 and Comparative Examples 1 to 7 was prepared in the same manner as in Example 1 using the components shown in Tables 1 and 2.

[0095] The type and content of the smoothing agent (A), the type and content of the nonionic surfactant (B), the type and content of the phosphorus compound (C), the type and content of the nitrogen-containing antioxidant (D), the type and content of the high molecular weight compound (E), and the type and content of other components in the treatment agent of each example are as shown in the "Smoothing agent (A)", "Nonionic surfactant (B)", "Phosphorus compound (C)", "Nitrogen-containing antioxidant (D)", "High molecular weight compound (E)", and "Other components" columns in Tables 1 and 2, respectively.

[0096] In addition, in the "pH" column, the pH of the treatment agent is the pH of a 1% aqueous solution of the treatment agent. The pH of the ion-exchanged water used to dilute the treatment agent when measuring the pH is 6.0 to 7.0 (25°C), and the value is measured within 30 minutes of creating the 1% aqueous solution. The pH measurement concentration condition is a 1% aqueous solution as a mixture that also contains the solvent in the treatment agent (water, paraffin, etc.). The pH measurement method in the "1% aqueous solution" columns of Tables 3 to 6 described below is the same.

[0097] [Table 1]

[0098] [Table 2] Details of the lubricating agent (A), nonionic surfactant (B), phosphorus compound (C), nitrogen-containing antioxidant (D), high molecular weight compound (E), and other ingredients listed in Tables 1 and 2 are as follows:

[0099] (Smoothing agent (A)) The lubricants shown in Table 3 below were used.

[0100] [Table 3] (Nonionic surfactant (B)) The nonionic surfactants shown in Table 4 below were used.

[0101] [Table 4] (Phosphorus Compounds (C)) The phosphorus compounds (C) shown in Table 5 below were used.

[0102] [Table 5] The numbers in parentheses in Table 5 indicate the P nucleus NMR integral ratio of each component when the sum of the P nucleus NMR integral ratios assigned to phosphate ester (C1a), phosphate ester (C1b), phosphate ester (C1c), and inorganic phosphoric acid or a salt thereof is taken as 100%.

[0103] (Nitrogen-containing antioxidants (D)) D-1: 1,3,5-tris(4-t-butyl-3-hydroxy-2,6-dimethylbenzyl)isocyanuric acid (Cyanox 1790, Cytec) rd-1: Tetrakis[methylene-3-(3',5'-di-t-butyl-4'-hydroxyphenyl)propionate]methane (ADEKA Corporation, trade name ADK STAB AO60) (High molecular weight compound (E)) E-1: A compound obtained by adding 40 moles of ethylene oxide to 1 mole of hydrogenated castor oil and esterifying the mixture with maleic acid and stearic acid (mass average molecular weight 6000) (pH of 1% aqueous solution: 4.3) (Other ingredients) Other ingredients shown in Table 6 below were used.

[0104] [Table 6] Test category 2 (initial evaluation of tar cleaning ability) Each of the various treatment agents prepared was uniformly diluted with ion-exchanged water or an organic solvent diluent as necessary to obtain a 15% dilution. The dilution was applied to oil-free polyethylene terephthalate fiber having 1670 decitex, 96 filaments, and an intrinsic viscosity of 0.93 by the oiling roller oiling method so that the amount applied was 5.0% as non-volatile matter, and the dilution was dried to obtain a test yarn.

[0105] The test yarn was run for 12 hours at an initial tension of 1.5 kg and a yarn speed of 0.1 m / min in contact with a matte chrome pin with a surface temperature of 250°C. The dirt on the matte chrome pin obtained in the above test was wiped off with a cotton swab soaked in a 5% sodium hydroxide glycerin solution, and the cleanability was evaluated according to the following criteria. The results are shown in the "Initial tar cleanability" column in Tables 1 and 2.

[0106] Initial evaluation criteria for tar cleaning performance 5 (Very good): The dirt can be wiped off with less than 10 wipes. 4 (Excellent): Dirt can be wiped off by wiping 10 to less than 50 times. 3 (Good): Dirt can be wiped off by wiping 50 to less than 100 times. 2 (Acceptable): If the dirt can be wiped off by wiping 100 to 200 times. 1 (Not acceptable): If the stain cannot be removed even after wiping 200 times or more Test category 3 (Evaluation of tar cleaning ability after high-temperature treatment) The various treatments prepared were stored in a sealed state at 60°C for 3 weeks, and then uniformly diluted with ion-exchanged water or an organic solvent diluent to obtain a 15% dilution. The dilution was applied to oil-free polyethylene terephthalate fiber having 1670 decitex, 96 filaments, and an intrinsic viscosity of 0.93 by the oiling roller oiling method so that the amount applied was 5.0 mass% as non-volatile content, and the diluent was dried to obtain a test yarn.

[0107] The test yarn was run for 12 hours at an initial tension of 1.5 kg and a yarn speed of 0.1 m / min in contact with a matte chrome pin with a surface temperature of 250°C. The dirt on the matte chrome pin obtained in the above test was wiped off with a cotton swab soaked in a 5% sodium hydroxide glycerin solution, and the cleanability was evaluated according to the following criteria. The results are shown in the "Tar cleanability after high temperature treatment" column in Tables 1 and 2.

[0108] Tar cleaning performance evaluation criteria after high temperature treatment 5 (Very good): The dirt can be wiped off with less than 10 wipes. 4 (Excellent): Dirt can be wiped off by wiping 10 to less than 50 times. 3 (Good): Dirt can be wiped off by wiping 50 to less than 100 times. 2 (Acceptable): If the dirt can be wiped off by wiping 100 to 200 times. 1 (Not acceptable): If the stain cannot be removed even after wiping 200 times or more From the results in the above table, it is clear that the present invention can improve the tar cleaning property and the tar cleaning property after high-temperature treatment of the treatment agent.

Claims

1. A synthetic fiber treatment agent comprising the following smoothing agent (A), a nonionic surfactant (B), and the following phosphorus compound (C), The agent for treating synthetic fibers, characterized in that a pH of a 1% by mass aqueous solution of the agent for treating synthetic fibers is 6.0 or more and 9.0 or less. Smoothing agent (A): A complete ester compound of an alcohol and a fatty acid. Phosphorus compound (C): at least one selected from the following phosphate ester (C1), organic phosphite ester (C2), and organic phosphonate ester (C3). Phosphate ester (C1): A phosphate ester including a phosphate ester (C1a) represented by the following formula (1), a phosphate ester (C1b) represented by the following formula (2), and a phosphate ester (C1c) represented by the following formula (3). 【Chemistry 1】 (In formula (1), R 1 A residue obtained by removing a hydroxyl group from an aliphatic monohydric alcohol having 8 to 24 carbon atoms, or a residue obtained by removing a hydroxyl group from an alkylene oxide having 2 to 3 carbon atoms, in total, added in an amount of 1 to 20 moles per mole of an aliphatic monohydric alcohol having 8 to 24 carbon atoms. M 1 , M 2 : Hydrogen atom, alkali metal, alkaline earth metal (1 / 2), organic amine salt, ammonium, or phosphonium. 【Chemistry 2】 (In formula (2), R 2 , R 3 A residue obtained by removing a hydroxyl group from an aliphatic monohydric alcohol having 8 to 24 carbon atoms, or a residue obtained by removing a hydroxyl group from an alkylene oxide having 2 to 3 carbon atoms, in total, added in an amount of 1 to 20 moles per mole of an aliphatic monohydric alcohol having 8 to 24 carbon atoms. M 3 : Hydrogen atom, alkali metal, alkaline earth metal (1 / 2), organic amine salt, ammonium, or phosphonium. 【Chemistry 3】 (In formula (3), R 4 , R 5 A residue obtained by removing a hydroxyl group from an aliphatic monohydric alcohol having 8 to 24 carbon atoms, or a residue obtained by removing a hydroxyl group from an alkylene oxide having 2 to 3 carbon atoms, in total, added in an amount of 1 to 20 moles per mole of an aliphatic monohydric alcohol having 8 to 24 carbon atoms. n: an integer of 2 or 3. M 4 : Hydrogen atom, alkali metal, alkaline earth metal (1 / 2), organic amine salt, ammonium, or phosphonium. However, M 4 When there are two or more, they may be the same or different.)

2. 2. The agent for treating synthetic fibers according to claim 1, wherein the phosphorus compound (C) is a phosphoric acid ester (C1).

3. The smoothing agent (A) contains a complete ester compound (A1) of a polyhydric alcohol and a monovalent fatty acid, 2. The agent for treating synthetic fibers according to claim 1, wherein the complete ester compound (A1) of a polyhydric alcohol and a monohydric fatty acid has a molecular weight of 700 or more.

4. 2. The synthetic fiber treatment agent according to claim 1, wherein the synthetic fiber treatment agent contains the smoothing agent (A) in an amount of 20% by mass or more and 70% by mass or less, the nonionic surfactant (B) in an amount of 20% by mass or more and 79.999% by mass or less, and the phosphorus compound (C) in an amount of 0.001% by mass or more and 10% by mass or less, assuming that the total content of the smoothing agent (A), the nonionic surfactant (B), and the phosphorus compound (C) is 100% by mass.

5. 2. The synthetic fiber treatment agent according to claim 1, further comprising water, the content of water in the synthetic fiber treatment agent being 0.001% by mass or more and 10% by mass or less.

6. 2. The agent for treating synthetic fibers according to claim 1, further comprising a nitrogen-containing antioxidant (D).

7. 2. The synthetic fiber treating agent according to claim 1, further comprising the following high molecular weight compound (E): High molecular weight compound (E): A compound containing a carbonyl group in the molecule and having a mass average molecular weight of 4,000 or more.

8. A method for filling a container with the synthetic fiber treating agent according to any one of claims 1 to 7 so that the filling rate relative to the volume of the container is 80% or more.

9. A method for producing synthetic fibers, comprising a step of applying the synthetic fiber treating agent according to any one of claims 1 to 7 to synthetic fibers.

Citation Information

Patent Citations

  • Partial metal plating of synthetic resin molded article

    JP1980000745A

  • Guide for fluid inlet port

    JP1982093607A

  • Treatment agent for synthetic fiber and synthetic fiber

    JP2022159712A

  • Treatment agent for synthetic fiber and synthetic fiber

    JP2022159713A

  • Processing method for synthetic fiber filament thread

    JP3649422B2

Cited By

  • Treatment agent for synthetic fiber, method for filling container, and method for producing synthetic fiber

    WO2025206123A1